| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 06, 2013 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,000 | -- | 7,000 | |
| Aug 06, 2013 | SVP, Business Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,438 | -- | 24,550 | |
| Aug 06, 2013 | SVP, Business Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,714 | -- | 17,714 | |
| Aug 06, 2013 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,000 | -- | 13,863 | |
| Aug 06, 2013 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,000 | -- | 7,000 | |
| Aug 06, 2013 | SVP, GM - International | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,382 | -- | 21,890 | |
| Aug 06, 2013 | SVP, GM - International | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,531 | -- | 17,531 | |
| Aug 06, 2013 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,000 | -- | 24,950 | |
| Aug 06, 2013 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,000 | -- | 7,000 | |
| Aug 06, 2013 | SVP, GM - Oncology | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,345 | -- | 28,080 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.